25

  • Phase 2 trial for GLPG0259

    Galapagos has started a phase 2 clinical study for its flagship program GLPG0259, a novel drug being developed for rheumatoid arthritis (RA). In this clinical trial, the safety and efficacy of this novel candidate drug will be tested in RA patients.…

    25 | 11 October 2010

  • PPD Celebrates 25th Anniversary

    PPD has announced that it is celebrating 25 years as one of the world's leading contract research organizations. Founded in 1985 as a one-person consulting firm by Fred Eshelman, PPD went public in early 1996. Over the past 25 years, PPD has stre…

    25 | 04 February 2010

  • Biotron Progresses HIV Clinical Trial in Australia

    An international AIDS conference has been told that an Australian anti-viral drug in development is able to stop the virus spreading. The drug, developed by Sydney based company Biotron and known as BIT225 was tested in a study involving 18 HIV p…

    25 | 24 December 2009

  • GE Launches US$250 Million Healthymagination Fund

    GE has announced the formation of the “GE Healthymagination Fund”, an equity fund that will make investments in promising healthcare technology companies. The fund will invest in companies globally that have innovative diagnostic, IT, and life sc…

    25 | 11 November 2009

  • Proteomics International Receives ISO Accreditation

    Proteomics International has been awarded accreditation under ISO 17025 by Australia’s accreditation agency, National Association of Testing Authorities (NATA). This accreditation is the first time globally that a proteomics service laboratory has …

    25 | 03 September 2009

  • Fluidigm Singapore Manufactures 250 Millionth Valve

    Fluidigm has announced that its Singapore biochip factory has manufactured and shipped more than 250 million microscopic NanoFlex valves. The valves stop or release the flow of liquids containing genetic samples and reagents in microfluidic chips…

    25 | 02 September 2009

  • Micro Leak Tester for Pharmaceutical Packaging

    The VeriPac 325/LV micro leak tester from PTI Inspection Systems is a non-destructive inspection system that allows integrity testing. It permits sensitive micro leak detection of empty syringes, liquid-filled syringes and liquid filled and lyophiliz…

    25 | 12 March 2009

  • Dabur Pharma FY08 revenue at Rs. 2503 million

    The Board of Dabur Pharma Ltd. has reported the audited financial results of the company for the quarter and fiscal ended March 31, 2008. Consolidated revenues were at Rs. 2783 million in FY08, as against Rs. 3267 million in FY 07. The companyâ…

    25 | 10 June 2008

  • Novartis Acquires 25% Stake In Alcon

    Novartis has reached an agreement with Nestlé S.A. providing the right to acquire majority ownership of Alcon Inc. in two steps and add the world leader in eye care to its diversified portfolio focused on growth areas of healthcare. The transact…

    25 | 09 April 2008

  • Report: Antibiotics Market to Recover Reaching $25 Billion by 2010

    Report Buyer, the online destination for business intelligence for major industry sectors, has now added a new report on the improving Antibiotics market. “Anti-Infectives, Vol II: Antibacterials,” forecasts a steady recovery and growth to more t…

    25 | 09 May 2007

Page 1 Next > Last >>